EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Gegen Qinlian Decoction, a classic traditional Chinese medicine formula: a potential therapeutic strategy for ulcerative colitis and colorectal cancer

Yijun Hou, Han Wang, Jitong Li, Chang Li, Yanting Sun, Yurui Wang, Dixin Zou, Liya Zhou

Frontiers in Pharmacology · 15.07.2026 · 17

DOI: 10.3389/fphar.2026.1868875 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 15.07.2026. Verfasst von Yijun Hou und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 263 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gegen Qinlian Decoction (GQD), a classic traditional Chinese medicine formula recorded in Shang Han Lun, has been used clinically for approximately two thousand years. In recent years, its potential roles in ulcerative colitis (UC) and colorectal cancer (CRC) have attracted increasing attention because of the multi-component, multi-target, and multi-pathway regulatory characteristics of traditional Chinese medicine (TCM). UC is a chronic relapsing inflammatory disease and an important risk factor for CRC. Although emerging immunomodulators, biologics, and targeted therapies have achieved certain efficacy in the treatment of UC and CRC, limited response, drug resistance, adverse effects, and disease recurrence remain major challenges for some patients. Persistent intestinal inflammation can disrupt the epithelial barrier, alter gut microbiota, induce immune imbalance, enhance oxidative stress, and activate pro-tumorigenic signaling, thereby contributing to the transition from UC to CRC. Within this inflammation-to-cancer framework, preclinical evidence suggests that GQD may exert comprehensive regulatory effects on multiple pathological processes. It may suppress inflammatory signaling pathways such as TLR4/NF-κB, IL-6/JAK2/STAT3, and the NLRP3 inflammasome, regulate Th17/Treg balance and macrophage polarization, restore epithelial barrier integrity, reshape gut microbiota homeostasis, and modulate oxidative stress, abnormal cell death, and metabolic dysregulation. These effects may act synergistically to limit the transition from an inflammatory microenvironment to a pro-tumorigenic microenvironment. In established CRC, GQD appears more suitable as a potential adjunctive therapy rather than a primary cytotoxic anticancer agent, with possible roles in reducing inflammation-associated tumor-promoting signals, remodeling the tumor immune microenvironment, enhancing responses to chemotherapy or immunotherapy, and mitigating treatment-related intestinal toxicity. In summary, GQD may have potential important value in the treatment of UC and CRC, and this review provides a reference for future research and clinical application.

Schlagwörter

Stichwörter der Autor:innen

Gegen Qinlian DecoctionInflammation–carcinogenesis transitioncolitis-associated colorectal cancercolorectal cancergut microbiotaintestinal barriertraditional Chinese medicineulcerative colitis

Autor:innen und Institutionen

  • College of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, China.
  • Department of Hepatology, Splenology and Gastroenterology, The First Affiliated Hospital of Changchun University of Traditional Chinese Medicine, Changchun, China.
  • Basic Medical College, Changchun University of Chinese Medicine, Changchun, China.
  • State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.

Zitieren

APA

Hou, Y., Wang, H., Li, J., Li, C., Sun, Y., Wang, Y., Zou, D., & Zhou, L. (2026). Gegen Qinlian Decoction, a classic traditional Chinese medicine formula: a potential therapeutic strategy for ulcerative colitis and colorectal cancer. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1868875

Vancouver

Hou Y, Wang H, Li J, Li C, Sun Y, Wang Y, et al. Gegen Qinlian Decoction, a classic traditional Chinese medicine formula: a potential therapeutic strategy for ulcerative colitis and colorectal cancer. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1868875

BibTeX
@article{Hou2026,
  author = {Hou, Yijun and Wang, Han and Li, Jitong and Li, Chang and Sun, Yanting and Wang, Yurui and Zou, Dixin and Zhou, Liya},
  title = {Gegen Qinlian Decoction, a classic traditional Chinese medicine formula: a potential therapeutic strategy for ulcerative colitis and colorectal cancer},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1868875}
}
Kostenlos starten →